How to induce magnetism in graphene

Graphene, a two-dimensional structure made of carbon, is a material with excellent mechani-cal, electronic and optical properties. However, it did not seem suitable for magnetic applica-tions. Together with international partners, Empa researchers have now succeeded in synthesiz-ing a unique nanographene predicted in the 1970s, which conclusively demonstrates that car-bon in very specific forms has magnetic properties that could permit future spintronic applica-tions. The results have just been published in the renowned journal Nature Nanotechnology.

Holiday Dinner With a Side of Impeachment Hearings

Sitting down to a holiday season meal with friends and family can be fun, but it can also be a recipe for disaster if it serves up political opinions, invasive questions and family gossip. This time of year can be stressful, and the recent impeachment hearings and divisive political climate only add to the potential tension, say mental health professionals. Chaplains and mental health counselors at Cedars-Sinai offer tips on navigating holiday dinners and get-togethers.

New Mayo Clinic studies to be presented at American Society of Hematology meeting

Mayo Clinic researchers will present findings at the American Society of Hematology Annual Meeting Dec. 7–10 in Orlando.
New Mayo Clinic studies to be presented include:
DNA analysis identifies elevated risk factor for myeloma in individuals of African ancestry
Study identifies more precise assessment measures for patients newly diagnosed with chronic lymphocytic leukemia
Researchers develop method to assess cancer-fighting cell therapy’s effectiveness

Small Mutations Identified through Deep DNA Sequencing for AML and MDS

Deep DNA sequencing analysis conducted by Rutgers Cancer Institute of New Jersey investigators examining genomic differences within tumors for prediction of disease relapse in certain hematologic malignancies has identified small mutations. These may help further guide treatment decision making for patients.

Retrospective Analysis Shows Proton Therapy Well Tolerated in Patients Undergoing Breast Conserving Surgery

Investigators at Rutgers Cancer Institute of New Jersey conducted a retrospective review of patients treated with proton therapy following breast-conserving surgery and found acceptable toxicity rates along with good-to-excellent patient-reported cosmetic outcomes.

Argonne’s debt to 2019 Nobel Prize for lithium-ion battery

A roar of approval rang out at the U.S. Department of Energy’s (DOE’s) Argonne National Laboratory upon the announcement in October that John B. Goodenough, M. Stanley Whittingham and Akira Yoshino had won the 2019 Nobel Prize in Chemistry. On December 10th in Stockholm, they received this highly coveted prize for their major contributions to the invention of the lithium-ion battery, which is a long-standing major focus of research at Argonne.

Battery collaboration meeting discusses new pathways to recycle lithium-ion batteries

At a conference held by the ReCell Center, an advanced battery recycling collaboration based at Argonne, representatives from industry, government, and academia discussed innovative approaches for lithium-ion battery recycling.

Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients

New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.

Researchers identify ‘Achilles’ heel’ of drug-resistant superbug

Researchers at The University of Texas Health Science Center at Houston (UTHealth) have identified a protein that allows vancomycin-resistant enterococci to defy antibiotic treatment and immune system attacks. Their discovery opens the door for future treatment options in the fight against antibiotic resistance.

Natural Toxins in the Global Food Supply Continue to Threaten the Health of Underprivileged Communities

Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health effects,, is also linked to vaccine resistance, and for the first time the global burden of disease from foodborne arsenic, lead, cadmium, and methyl mercury has been quantified.. The Society for Risk Analysis (SRA) will present new studies as part of its Global Disease Burden Caused by Foodborne Chemicals and Toxins symposium on Monday, Dec. 9 from 1:30-3:00 p.m. as part of its 2019 Annual Meeting at the Crystal Gateway Marriott in Arlington, Virginia. This symposium will provide updates to a 2015 World Health Organization (WHO) publication which analyzed the disease burdens caused by these toxins.

Medical Errors Remain Problem 20 Years after Critical Report on Patient Safety

Medical errors remain as vexing a problem, according to Bloomberg Distinguished Professor Kathleen Sutcliffe of Johns Hopkins University. She discusses the issue in her new book Still Not Safe: Patient Safety and the Middle-Managing of American Medicine, co-authored with Robert Wears.

Treatment with PD-1 inhibitor prior to stem cell transplant is safe, effective for patients with classic Hodgkin lymphoma, study finds

A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma.

Why Are Manga Outselling Superhero Comics?

Last year, the Japanese or Japanese-inspired comics and graphic novels reportedly outsold old-fashioned superhero comics for the first time ever in the United States, a trend expected to continue. Satoru Saito, an associate professor of Japanese literature at Rutgers University–New Brunswick, teaches courses on Japanese pop culture and anime which explore the foundations of these narrative forms and how they relate to the wider Japanese culture.

Edmondo Robinson Joins Moffitt Cancer Center as New Chief Digital Innovation Officer

Dr. Robinson has joined Moffitt as the new senior vice president, chief digital innovation officer. He is responsible for expanding Moffitt’s ecosystem from within and outside of health care to deliver on consumer-oriented, real-world solutions for clinical practice, research and administrative processes essential to support growth.